|
|
|
Insider
Information: |
Gill David N |
Relationship: |
Director |
City: |
Knoxville |
State: |
TN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
138,730 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,652,320 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
138,730 |
|
|
Total
Value |
$1,652,320 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Nxstage Medical, Inc. |
NXTM |
SVP & CFO |
2006-05-10 |
7,442 |
2006-05-10 |
0 |
Premium* |
|
Lemaitre Vascular Inc |
LMAT |
Director |
2007-05-16 |
6,805 |
2006-10-31 |
0 |
Premium* |
|
Endochoice Holdings, Inc. |
GI |
President and CFO |
2016-11-22 |
0 |
2016-11-22 |
0 |
Premium* |
|
Ocugen Ord Shs |
OCGN |
Director |
2017-08-16 |
14,000 |
2016-12-09 |
0 |
Premium* |
|
Melinta Therapeutics, Inc |
MLNT |
Director |
2018-05-25 |
6,000 |
2017-01-03 |
0 |
Premium* |
|
Strata Skin Sciences Inc |
SSKN |
|
2019-11-22 |
64,694 |
2018-06-08 |
0 |
Premium* |
|
Evolus Inc |
EOLS |
Director |
2024-05-14 |
33,964 |
2018-12-14 |
0 |
Premium* |
|
Strongbridge Biopharma Plc |
SBBP |
Director |
2021-10-05 |
0 |
2019-09-03 |
0 |
Premium* |
|
Y-Mabs Therapeutics Inc |
YMAB |
Director |
2024-06-11 |
5,825 |
2020-11-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2020-09-03 |
4 |
D |
$3.61 |
$83,405 |
D/D |
(23,104) |
66,896 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2020-09-24 |
4 |
B |
$2.13 |
$17,040 |
D/D |
8,000 |
74,896 |
2.39 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2020-11-03 |
4 |
OE |
$11.16 |
$44,640 |
D/D |
4,000 |
4,000 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2020-11-03 |
4 |
AS |
$45.00 |
$180,000 |
D/D |
(4,000) |
0 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2020-11-18 |
4 |
OE |
$11.16 |
$22,320 |
D/D |
2,000 |
2,000 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2020-11-18 |
4 |
AS |
$45.77 |
$91,530 |
D/D |
(2,000) |
0 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2021-01-19 |
4 |
AS |
$46.52 |
$93,045 |
D/D |
(2,000) |
0 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2021-01-19 |
4 |
OE |
$11.16 |
$22,320 |
D/D |
2,000 |
2,000 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
19,313 |
24,313 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-05-14 |
4 |
D |
$2.35 |
$44,826 |
D/D |
(19,075) |
55,821 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
95,821 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-10-01 |
4 |
D |
$2.06 |
$36,592 |
D/D |
(17,763) |
78,058 |
0 |
- |
|
SBBP |
Strongbridge Biopharma Pl... |
Director |
|
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(78,058) |
0 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2022-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,568 |
39,881 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2022-05-13 |
4 |
S |
$13.10 |
$69,584 |
D/D |
(5,313) |
34,568 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2022-05-16 |
4 |
S |
$13.62 |
$68,080 |
D/D |
(5,000) |
29,568 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2023-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
8,293 |
37,861 |
0 |
- |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,330 |
2,330 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,464 |
44,325 |
0 |
- |
|
EOLS |
Evolus Inc |
Director |
|
2024-05-13 |
4 |
S |
$12.72 |
$46,356 |
D/D |
(3,643) |
40,682 |
0 |
% |
|
EOLS |
Evolus Inc |
Director |
|
2024-05-14 |
4 |
S |
$12.60 |
$84,654 |
D/D |
(6,718) |
33,964 |
0 |
% |
|
YMAB |
Y-Mabs Therapeutics Inc |
Director |
|
2024-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,495 |
5,825 |
0 |
- |
|
SSKN |
Strata Skin Sciences Inc |
Director |
|
2018-06-08 |
4/A |
A |
$0.00 |
$0 |
D/D |
31,401 |
46,401 |
0 |
- |
|
48 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|